NT5E and colorectal carcinoma: We next examined whether these mono- or combinatorial regimens targeting the CD73 and adenosinergic pathways were effective for treating MC38-CRC, which expresses high levels of CD73 with low CAF abundancy (Supplementary Fig. 2).